Clinical trial
Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney…
NCT00056095 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00056095 |
|---|---|
| Title | Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer |
| Official title | Phase II Trial in Intrafamilial Allogeneic Cell Transplant in Patients With Metastatic Kidney Cancer |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | therapeutic allogeneic lymphocytes, cyclophosphamide, cyclosporine, fludarabine phosphate, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation |
| Enrollment | 57 |
| Start date | Nov 4, 2002 |
| Primary completion | Feb 13, 2008 |
| Completion | Aug 17, 2016 |
| First posted | Mar 7, 2003 |
| Last update posted | Feb 24, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: